With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and ...

The JV will leverage the dual-arm robot Maholo, developed by Yaskawa subsidiary the Robotic Biology Institute.

Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform ...

Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase ...

AI in pharmaceuticals is set for massive growth, expected to reach $16.49 billion by 2034, enhancing areas like drug discovery and personalized healthcare. However, ethical, technical, and ...

It is feared that going forward Pharma exports to the US would shrink as the higher tariff would make Indian drugs expensive. “The tariffs development reinforces the necessity for Indian ...

The United States joined Russia to vote against a UN General Assembly resolution condemning Russia’s war against Ukraine Monday in a stunning shift from years of US policy. The vote against the ...

Teva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab). The product is indicated ...

Credit: Igal Vaisman/Shutterstock. Teva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab ...

The U.S. health regulator has pulled up Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant. In a warning letter ...

Feb 21 (Reuters) - The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' (MIRM.O ... Updated ago Marketscategory Dollar firms on US trade policy anxiety; Nvidia provides little ...

With India supplying over 45 per cent of the US's generic drugs, analysts believe any additional costs from the proposed tariffs—reportedly up to 25 per cent—would be absorbed across consumers, ...